AEST.MED.INT.HLD.SP.ADR/3 (3FMA) — Long-term Investment Intensity
AEST.MED.INT.HLD.SP.ADR/3 (3FMA) has a Long-term Investment Intensity of 0.2% as of December 2022. Long-term investments of €1.16 Million represent 0.2% of total assets of €546.37 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check total reinvestment intensity of AEST.MED.INT.HLD.SP.ADR/3 to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
AEST.MED.INT.HLD.SP.ADR/3 Long-term Investment Intensity (2021–2022)
This chart shows how AEST.MED.INT.HLD.SP.ADR/3's Long-term Investment Intensity has evolved across 2 annual periods from 2021 to 2022. As of December 2022, the intensity stands at 0.2%, reflecting long-term investments of €1.16 Million against total assets of €546.37 Million EUR. Explore cash flow to debt ratio of AEST.MED.INT.HLD.SP.ADR/3 to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for AEST.MED.INT.HLD.SP.ADR/3 (2021–2022)
The table below presents the year-by-year Long-term Investment Intensity for AEST.MED.INT.HLD.SP.ADR/3 from 2021 to 2022, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see AEST.MED.INT.HLD.SP.ADR/3 stock valuation.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 0.2% | €1.16 Million | €546.37 Million | ▼ -0.6 pp |
| 2021 | 0.9% | €4.90 Million | €576.94 Million | — |